TAKEDA PHARMACEUTICAL CO LTD (TAK)
Clinical trial NCT06935266 updates: 1. completion date: 2025-09-22 → 2025-09-27 2. primary completion date: 2025-09-22 → 2025-09-27
Clinical trial NCT06935266 updates: 1. completion date: 2025-09-22 → 2025-09-27 2. primary completion date: 2025-09-22 → 2025-09-27
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical